Skip to content

Preoperative Sleep Intervention on Postoperative Delirium in Infants and Toddlers Undergoing Congenital Heart Surgery

The Impact of Behavioral Intervention On Postoperative Delirium In Sleep-Disordered Infants and Toddlers Undergoing Congenital Heart Surgery: A Multicenter, Randomized Controlled Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06861998
Enrollment
452
Registered
2025-03-06
Start date
2025-04-30
Completion date
2026-12-31
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease (CHD), Delirium - Postoperative, Sleep Problems

Brief summary

This is a multicenter, randomized, controlled clinical trial aimed to determine whether preoperative sleep interventions could reduce the incidence of adverse outcomes, such as postoperative delirium, in sleep-disordered infants and toddlers undergoing congenital heart surgery. The study will include infants and toddlers undergoing elective cardiac surgery with sleep disorders, assessed by the Brief Infant Sleep Questionnaire (BISQ). All participants will be randomly assigned to the intervention group and Controll group in a 1:1 ratio. The intervention group received sleep hygiene education and a bedtime routine based on touch, the control group received only sleep hygiene education. The primary outcome is the incidence of postoperative delirium within 7 days after surgery or before discharge, and secondary outcomes include postoperative sleep quality, pain score, perioperative organ injury (including AKI, acute lung injury, and postoperative liver dysfunction), clinical recovery and prognosis. The results of this study will provide suggestions for the prevention of delirium after cardiac surgery.

Detailed description

The study will be carried out in Fuwai Hospital, Chinese Academy of Medical Sciences, Anzhen Hospital Affiliated to Capital Medical University, Fuwai Central China Cardiovascular Hospital, Fuwai Cardiovascular Hospital of Yunnan Province, and Children's Hospital Affiliated to Capital Institute of Pediatrics. The research process is as follows: Perform routine sleep disorder assessments on pediatric patients visiting the outpatient clinic. Fully inform the guardians of pediatric patients with sleep disorders of all the contents and procedures of this trial. After obtaining informed consent comprehensively and having the informed consent forms signed, conduct further assessments on the pediatric patients to determine whether they meet the inclusion and exclusion criteria. All enrolled children's guardians will receive sleep hygine education in the outpatient clinic. After stratification by research center, the random block is set to 4 - 6, the R will be used to randomly assign subjects to the experimental group and the control group at a 1:1 ratio. After randomization, the children in the experimental group receive behavioral interventions every day before surgery, specifically a bedtime routine based on massage/stroking. Guardians need to strictly implement it and cooperate with the researchers through phone calls (during the waiting period for admission) or face-to-face communication (during the preoperative hospitalization period). In the control group, parents are provided with sleep hygiene education for infants and toddlers, and no additional intervention measures are applied. To better control the quality of interventions for children aged 0 - 3 in the experimental group, the daily implementation status of parents is counted for the degree of implementation (0 - 100%) in the WeChat mini-program. Guardians record the children's daily sleep diaries (online questionnaires) before surgery. The day before surgery, they fill out the Brief Infant Sleep Questionnaire (BISQ) again and compare it with the baseline situation. After admission, children wear actigraphs until the day of surgery and until discharge after surgery to automatically record sleep-related information. After the children are enrolled in the study, relevant researchers will supervise the implementation of cognitive-behavioral interventions for the children once a day before surgery to ensure that the actigraph device functions properly during hospitalization and remind guardians to record electronic sleep diaries until the night before surgery. Follow-up will be conducted within 7 days after surgery or before discharge to evaluate outcomes such as delirium and pain. The primary outcome is the incidence of postoperative delirium, and secondary outcomes include postoperative sleep quality, pain score, perioperative organ injury (including AKI, acute lung injury, and postoperative liver dysfunction), clinical recovery and prognosis.

Interventions

BEHAVIORALMessage-based bedtime routine

The intervention group implemented sleep hygiene education and the Message-based bedtime routine, including nutritional activities-hygiene-communication-message.

BEHAVIORALsleep hygiene education

Sleep hygiene education includes sleep environment, sleeping location, regular sleep schedule, bedtime routines, sleeping methods, and sleeping posture.

Sponsors

Yan Fuxia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Years
Healthy volunteers
No

Inclusion criteria

1. Age 0-3 years 2. Scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass. 3. Children with sleep disorders who are screened by the Brief Infant Sleep Questionnaire-Revised short form (BISQ-R SF).

Exclusion criteria

1. Infants and toddlers who have taken any relevant preoperative treatment for sleep problems 2. The risk adjustment in congenital heart surgery-1 (RACHS-1 classification) ≥4. 3. Preoperative history of cerebral ischemia and hypoxia, developmental disorders such as autism spectrum disorders, etc. 4. Presence of any other preoperative acute or chronic medical condition (mechanical ventilation support, history of asphyxia rescue, severe hepatic or renal dysfunction, or comorbidities with other non-cardiac malformations) 5. Concurrent participation in other clinical trials 6. Refusal of the family to sign the informed consent or poor compliance of the child.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative deliriumPostoperative 7 days

Secondary

MeasureTime frameDescription
Concentration of zonulinBefore surgery, at the end of surgery and 24 hours after surgeryOne of markers of intestinal injury
The length of intensive care unit stayFrom the end of the surgery to discharge from the hospital,up to 30 daysThe time spent in the intensive care unit.
The length of postoperative hospital stayFrom the end of the surgery to the day of discharge from the hospital,up to 30 days
Average daily costadmission to discharge, up to 30daystotal hospitalization cost divided by total length of stay
Mechanistic endpoint: Concentration of plasma S-100β proteinBefore surgery, at the end of surgery and 24 hours after surgeryS-100β protein was used as a surrogate biomarker for the disruption of the blood-brain barrier.
Postoperative sleep qualityPostoperative 7 days or before dischargePostoperative sleep quality was assessed using the Actigraph model wGT3X-BT body movement recorder. The Actigraph model wGT3X-BT was worn from the time of admission to 7 days after surgery in order to assess the sleep quality of the subjects.
Pain defined by the Face, Legs, Activity, Cry, and Consolability scalePostoperative 7 daysThe FLACC scale is a simple and effective tool used to assess pain in infants and non-verbal patients. It stands for Face, Legs, Activity, Cry, and Consolability. Each of these five items is scored on a scale of 0 to 2, with a higher score indicating a greater degree of pain. The total FLACC score, ranging from 0 to 10, provides a quick and reliable assessment of the patient's pain level.
The incidence of postoperative Acute kidney injuryWithin postoperative 7 days
The incidence of Pulmonary complicationPostoperative 7 days
The incidence of postoperative Liver dysfunctionPostoperative 7 days
Concentration of intestinal fatty acid binding protein (I-FABP)Before surgery, at the end of surgery and 24 hours after surgeryone of markers of intestinal injury
Concentration of lipopolysaccharide (LPS)Before surgery, at the end of surgery and 24 hours after surgeryOne of markers of intestinal injury
Concentration of lipopolysaccharide binding protein (LBP)Before surgery, at the end of surgery and 24 hours after surgeryOne of markers of intestinal injury
Types and dosages of drugs used for postoperative sedation and analgesiaPostoperative 7 days or before discharge
Levels of inflammatory cytokinesBefore surgery, at the end of surgery and 24 hours after surgeryThe inflammatory cytokines include IL-6,TNF-α,IL-1β,IFN-γ,IL-17, C-reactive protein.
Neutrophil-to-lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR)Before surgery, 24 hours after surgeryNeutrophil-to-lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) are two blood biomarkers based on blood cell counts, which reflect the inflammatory and immune status of the body; they were obtained based on preoperative and postoperative blood routine tests.
The duration of postoperative mechanical ventilationFrom the end of the surgery to discharge from the hospital,up to 30 daysThe total hours needing mechanical ventilation support

Other

MeasureTime frameDescription
1-Year Mortality and Survival1 year after dischargeThe rate at which patients die and survive within 1 year of discharge from the hospital.
Readmission rate30 days/6 months/1 year after dischargethe rate at which a patient is readmitted to the hospital for the same or a different health problem within 30 days/six months/1 year after discharge
Long-term Sleep quality score30 days, 6 months, 1 year after dischargeguardians scored sleep quality 1-5 using a sleep diary

Countries

China

Contacts

Primary ContactFuxia Yan
yanfuxia@sina.com010-88396628

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026